private financing
Kurome Therapeutics Raises $15 Million in Series A Financing
The preclinical company is developing dual IRAK1/4 and panFLT3 inhibitors for the treatment of acute myeloid leukemia.
Aerpio Pharmaceuticals, Aadi Bioscience to Merge; Aim to Raise $155 in PIPE Financing
Aerpio will become part of Aadi Bioscience, and the combined company will focus on advancing Aadi's mTOR inhibitor in genetically altered cancers.
Kinnate Biopharma Raises $35M to Establish Chinese Joint Venture
The JV will focus on developing Kinnate's RAF inhibitor and FGFR inhibitor in the Greater China market.
Flare Therapeutics Launches With $82M in Series A Financing
The Cambridge, Massachusetts-based biotech will initially focus on developing precision oncology drugs that target transcription factor dysregulation.
Nuvalent Raises $135M in Series B Funding
The company will use the funding to advance its lead NSCLC treatments, a ROS inhibitor and ALK inhibitor, into the clinic.
Mar 16, 2021
Acepodia Raises $47M in Series B Financing
Feb 17, 2021
Cancer Detection Firm Micronoma Raises $3.5M
Jan 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Jan 13, 2021
OncoLens Raises $7.25 Million in Series A Funding
Dec 28, 2020
Gritstone Raises $125M in Private Financings
Aug 20, 2020
Biofidelity Raises $12M in Series A Funding Round
Jun 11, 2019
Saga Diagnostics Raises $4.2M
May 30, 2019